The clonal hematopoiesis mutation Jak2 aggravates endothelial injury and thrombosis in arteries with erosion-like intimas
Authors:
Top Cited Papers
- 16 May 2024
- journal article
- research article
- Published by Elsevier in International Journal of Cardiology
- Vol. 409, 132184
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- The JAK–STAT pathway: an emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasmsEuropean Heart Journal, 2021
- New Insights Into Plaque Erosion as a Mechanism of Acute Coronary SyndromesJAMA, 2021
- Clonal Hematopoiesis and Risk of Atherosclerotic Cardiovascular DiseaseNew England Journal of Medicine, 2017
- Temporal shifts in clinical presentation and underlying mechanisms of atherosclerotic diseaseNature Reviews Cardiology, 2016
- Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarctionEuropean Heart Journal, 2015
- Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia VeraNew England Journal of Medicine, 2015
- Cardiovascular risk in post-myocardial infarction patients: nationwide real world data demonstrate the importance of a long-term perspectiveEuropean Heart Journal, 2015
- Age-Related Clonal Hematopoiesis Associated with Adverse OutcomesNew England Journal of Medicine, 2014
- A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for MyelofibrosisNew England Journal of Medicine, 2012
- Physiological Jak2V617F Expression Causes a Lethal Myeloproliferative Neoplasm with Differential Effects on Hematopoietic Stem and Progenitor CellsCancer Cell, 2010